ACC 2020: ISCHEMIA Trial Shows No Benefit of Revascularization Even for Most Severe Ischemia and Coronary Artery Disease
Despite higher risks observed in these groups, benefits of revascularization over conservative management were not apparent
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.